Epic Update : Ranbaxy Laboratories

Ranbaxy Laboratories’ Commercial Paper (CP)/Short Term Debt (STD) programme for an enhanced amount of Rs 800 crore. Earlier CP/STD programme of the company for Rs 1,200 crore was also assigned the same rating.



http://www.epicresearch.co/



0731-664-2300

Posted in: Indian Market Tips